ALBKY

ALBKY remains in a Stage 2 advancing regime within its broader uptrend, with the recent pullback finding support at the flat-to-rising 9 and 20 EMAs and holding above the 50 DMA. Neutral OB/OS conditions and the Value + EPS strategy favor entries at this EMA zone, but short-term consolidation and flat EMAs warrant awaiting a clear acceptance above the EMAs before committing.

• ↑Net profit €943 m in 2025, up 44% YoY; ROTE 13.9%
• ↑Corporate lending pipeline set to expand by over €3.5 bn in 2025
• ↓NII growth pressured as rates fell faster to ~2%, limiting margins